HealthcarePrenatal exposure to phentermine-topiramate lower under safety program

Prenatal exposure to phentermine-topiramate lower under safety program


Prenatal exposure to phentermine-topiramate lower under safety program

Under the Risk Evaluation and Mitigation Strategy (REMS), prenatal exposure to phentermine-topiramate is lower than topiramate and other antiobesity medications (AOMs), according to a study published online March 21 in the Annals of Internal Medicine.

Noting that the U.S. Food and Drug Administration approval of phentermine-topiramate for required a REMS to prevent , Amir Sarayani, Pharm.D., M.P.H., Ph.D., from the University of Florida in Gainesville, and colleagues conducted a involving females aged 12 to 55 years to examine the rate of prenatal exposure, contraceptive use, and pregnancy testing with phentermine-topiramate compared to topiramate or other AOMs. Overall, 156,280 treatment episodes were included.

The researchers found that at treatment initiation, the adjusted prevalence of pregnancy was 0.9 versus 1.6 per 1,000 episodes for phentermine-topiramate versus topiramate (prevalence ratio, 0.54). For phentermine-topiramate versus topiramate, the incidence rate of conception during treatment was 9.1 versus 15.0 per 1,000 person-years (rate ratio, 0.61). Compared with AOMs, for phentermine-topiramate, both outcomes were similarly lower. Prenatal exposure was slightly lower in topiramate versus AOM users. In all cohorts, approximately 20 percent of patients had at least 50 percent of treatment days covered by contraceptives. Furthermore, ≤5 percent of had pregnancy tests before treatment, but this was more common among phentermine-topiramate users.

“Potential exposures were detected, suggesting the need for further clinical vigilance and risk mitigation,” the authors write.

More information:
Amir Sarayani et al, Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine–Topiramate to Prevent Exposure During Pregnancy, Annals of Internal Medicine (2023). DOI: 10.7326/M22-1743

Copyright © 2023 HealthDay. All rights reserved.

Citation:
Prenatal exposure to phentermine-topiramate lower under safety program (2023, March 22)
retrieved 22 March 2023
from https://medicalxpress.com/news/2023-03-prenatal-exposure-phentermine-topiramate-safety.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Original Source Link

Latest News

Kenan Thompson Says to ‘Investigate More’ After ‘Quiet on Set’ Doc – Hollywood Life

View gallery Kenan Thompson opened up about his thoughts on the bombshell documentary Quiet on Set during an appearance on The Tamron Hall...

Chocolate eggs and bunnies are more expensive than ever

Shoppers may get a bitter surprise in their Easter baskets this year. Chocolate eggs and bunnies are more expensive than...

Mandiant: Yevgeny Prigozhin-linked online influence operations are active months after his death in August 2023, and underwent subtle shifts in their targeting (Dustin Volz/Wall...

Dustin Volz / Wall Street Journal: Mandiant: Yevgeny Prigozhin-linked online influence operations are active months after his death...

Stephen Colbert Rips Apart The Trump Bible Con

Stephen Colbert took apart Trump’s selling of Bibles con by pointing out Trump is charging $60 for writing...

‘Richly decorated’ Roman villa with ‘curse tablets’ and tiny axes unearthed in England

A "remarkable" Roman villa complex unearthed by archaeologists in England contains miniature axes and other artifacts that may...

Must Read

- Advertisement -

You might also likeRELATED
Recommended to you